Biome Grow (Biome Grow) Debt-to-Equity : -0.87 (As of Sep. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Biome Grow Debt-to-Equity?

Biome Grow's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $3.09 Mil. Biome Grow's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.00 Mil. Biome Grow's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $-3.56 Mil. Biome Grow's debt to equity for the quarter that ended in Sep. 2023 was -0.87.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Biome Grow's Debt-to-Equity or its related term are showing as below:

BIOIF' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.67 Med: 0.15 Max: 2.55
Current: -0.87

During the past 10 years, the highest Debt-to-Equity Ratio of Biome Grow was 2.55. The lowest was -1.67. And the median was 0.15.

BIOIF's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.29 vs BIOIF: -0.87

Biome Grow Debt-to-Equity Historical Data

The historical data trend for Biome Grow's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biome Grow Debt-to-Equity Chart

Biome Grow Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

Get a 7-Day Free Trial

0.42

0.57

0.55

-0.94

Biome Grow Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial															-1.67	-1.30	-0.94	-0.90	-0.87

Competitive Comparison of Biome Grow's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Biome Grow's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biome Grow's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biome Grow's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Biome Grow's Debt-to-Equity falls into.

Biome Grow Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Biome Grow's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.059	+	0)	/	-3.254
	=	-0.94

Biome Grow's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.088	+	0)	/	-3.561
	=	-0.87

Biome Grow (OTCPK:BIOIF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Biome Grow Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Biome Grow's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Biome Grow (Biome Grow) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biome Grow Inc (OTCPK:BIOIF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

BIO:Canada

Address

480 University Avenue, Suite 1401, Toronto, ON, CAN, M5G 1V2

Website

https://www.biomegrow.com

Biome Grow Inc is a Canada-based company engaged in medical and recreational cannabis businesses. Along with its subsidiaries, the firm is engaged in the cultivation of marijuana plants, dried marijuana and marijuana seeds. The company through its Weed VR platform connects customers with growers and distributors as well as retail partners.